yahoo_financeOriginal article
Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough
Data ReadoutpositiveCancer VaccinePositive
AI Analysis
Summary
Moderna has become the S&P 500's second-best performing stock this year following positive cancer vaccine breakthrough results, drawing praise from Wall Street analysts, Jim Cramer, and Elon Musk.
Importance:7/10
Sentiment:
0.80
cancer vaccinebreakthroughstock performanceS&P 500
Read the original article
Published by yahoo_finance on August 20, 2026 2:20 AM